Bernadette Connaughton, Director: Halozyme Therapeutics HALO Sell · Filed 06/02

Trade details

Type: Insider sale
Amount: $107,591.25
Shares · price: 1,625 sh · $66.21 a share
Held after: 43,669 sh
Stock: Halozyme Therapeutics HALO
Person: Bernadette ConnaughtonDirector
Trade date: 26/06/01
Filed: 26/06/02
Days to filing: 1 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 05/02~07/01

Bernadette Connaughton's recent trades

Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$167.7K
1,626 sh
$167.7K
Filed 08/10
Traded 08/10
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$103.2K
1,625 sh
$103.2K
Filed 05/05
Traded 05/01
Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$310.3K
4,875 sh
$310.3K
Filed 05/01
Traded 05/01
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$140.5K
2,000 sh
$140.5K
Filed 01/06
Traded 01/05
Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$140.6K
2,000 sh
$140.6K
Filed 01/05
Traded 01/05